Sarcoma trials in United States
300 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMolecular Analysis Of Solid Tumors
- Where
- Memphis
- Age
- Up to 25 years
- People
- 1,000
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT01050296 - No phaseTaking peoplePediatric Radiation Therapy Registry
- Where
- Baltimore, Washington D.C.
- Age
- 0 years to 26 years
- People
- 5,000
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07129317 - Phase 1Not yet taking people in United StatesCytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
- Where
- Seattle
- Age
- 21 years and over
- People
- 21
- Run by
- Seattle Children's Hospital
See details and how to joinNCT07224568 - Phase 1Taking peopleImmunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Where
- Houston
- Age
- Up to 21 years
- People
- 21
- Run by
- Baylor College of Medicine
See details and how to joinNCT06198296 - No phaseTaking peopleWATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
- Where
- Rochester
- Age
- 18 years and over
- People
- 250
- Run by
- Mayo Clinic
See details and how to joinNCT07058064 - Phase 1Taking peopleShort Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
- Where
- Boston
- Age
- 18 years and over
- People
- 6
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06812052 - Phase 1Taking peopleQ702 for the Treatment of Patients With Hematologic Malignancies
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 46
- Run by
- Mayo Clinic
See details and how to joinNCT06712810 - Phase 1/2Taking peopleA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Where
- Boston, Dallas, Fairfax, Gilbert, Pittsburgh
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- ImmVira Pharma Co. Ltd
See details and how to joinNCT04370587 - No phaseTaking peopleCohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
- Where
- Nashville
- People
- 2,100
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06482957 - Phase 2Taking peopleA Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Where
- Aurora, Birmingham, Columbus, Salt Lake City, The Bronx, Washington D.C.
- Age
- 18 months to 40 years
- People
- 86
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05135975 - Phase 1/2Taking people64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Where
- Cincinnati, Duarte, Grand Rapids, Orange, Stanford
- Age
- 15 years and over
- People
- 26
- Run by
- Lantheus Medical Imaging
See details and how to joinNCT06298916 - Early phase 1Taking peopleA Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
- Where
- Shreveport
- Age
- 18 years and over
- People
- 12
- Run by
- Pure Biologics S.A.
See details and how to joinNCT06700070 - No phaseTaking peopleBeliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 300
- Run by
- University of Utah
See details and how to joinNCT06875700 - Phase 2Taking peopleHypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
- Where
- Nashville
- Age
- 18 years and over
- People
- 40
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT04506008 - Early phase 1Not yet taking people in United StatesLipid Mediators & Cancer: Montelukast, SPM, and Almonds
- Where
- Tampa
- Age
- 18 years and over
- People
- 56
- Run by
- University of South Florida
See details and how to joinNCT06887673 - No phaseTaking peopleSpecimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Where
- Chicago
- Age
- 18 years to 80 years
- People
- 6,000
- Run by
- Northwestern University
See details and how to joinNCT00005095 - Phase 1/2Taking peopleSAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
- Where
- Santa Monica
- Age
- 18 years and over
- People
- 250
- Run by
- Sarcoma Oncology Research Center, LLC
See details and how to joinNCT03138161 - Phase 2Taking peopleTalimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
- Where
- Santa Monica
- Age
- 18 years and over
- People
- 200
- Run by
- Sarcoma Oncology Research Center, LLC
See details and how to joinNCT03886311 - Phase 2Taking peopleMetronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
- Where
- Santa Monica
- Age
- 18 years and over
- People
- 80
- Run by
- Sarcoma Oncology Research Center, LLC
See details and how to joinNCT04535271 - No phaseTaking peopleBostonGene and Exigent Genomic INsight Study
- Where
- Albuquerque, Fort Wayne, Houston, Puyallup, Rogers, Stockton, Tulsa
- Age
- 18 years and over
- People
- 400
- Run by
- BostonGene
See details and how to joinNCT06272864 - Phase 1Not yet taking people in United StatesEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Where
- Seattle
- Age
- 18 years and over
- People
- 55 worldwide
- Run by
- Medigene AG
See details and how to joinNCT06748872 · EU 2024-516787-28-00 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Cleveland, Jacksonville, New York, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - No phaseTaking peopleGenomic Risk in Retroperitoneal Sarcoma
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 50
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT06436846 - No phaseNot yet taking people in United StatesInvestigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 500
- Run by
- Power Life Sciences Inc.
See details and how to joinNCT06264505 - No phaseTaking peopleREtroperitoneal SArcoma Registry: an International Prospective Initiative
- Where
- Boston, Columbus, Emory, Jacksonville, Los Angeles, Tampa
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT03838718